For this purpose, we selected CpG sites within 200 bp from transcription start sites (TSS200) for two tumor-suppressor genes (cg22879515 (MIR34B) [26], and cg23180938 (CDO1) [27]), and assessed distributions of their β values obtained in the initial genome-wide methylation analysis. This evidence concerns the gene CDO1 and neoplasm.